Clinical Trial 43164

share

Los Angeles, CA 90024


Study Summary:

Study STS101-002 is a randomized, double-blind, parallel group, placebo-controlled, multicenter study to evaluate the efficacy, safety, and tolerability of single doses of STS101 (dihydroergotamine nasal powder) in the acute treatment of migraine.


Key Inclusion Criteria:

  • Males or females
  • 18-65 years of age at the time of Screening Visit
  • Subject has at least 1-year history of migraines, with or without aura
  • Must have in-tact nasal passage


Qualified Participants May Receive:

Compensation of $100 for up to three (3) completed study visits up to three (3) months + compliance bonus for e-diary completion


Study is Available At:

Cal Neuro Research Group
10850 Wilshire Blvd., Suite 1260
Los Angeles, CA 90024
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.